Briefing From The Editor -- WELL Stock

Welltower logged a 0.5% change during today's morning session, and is now trading at a price of $79.75 per share. The S&P 500 index moved 0.0%. WELL's trading volume is 161,298 compared to the stock's average volume of 2,039,306.

Welltower trades -10.52% away from its average analyst target price of $89.12 per share. The 17 analysts following the stock have set target prices ranging from $78.0 to $96.0, and on average have given Welltower a rating of buy.

If you are considering an investment in WELL, you'll want to know the following:

  • Welltower's current price is 313.4% above its Graham number of $19.29, which implies that at its current valuation it does not offer a margin of safety

  • Welltower has moved 30.0% over the last year, and the S&P 500 logged a change of 13.0%

  • Based on its trailing earnings per share of 0.26, Welltower has a trailing 12 month Price to Earnings (P/E) ratio of 306.7 while the S&P 500 average is 15.97

  • WELL has a forward P/E ratio of 73.2 based on its forward 12 month price to earnings (EPS) of $1.09 per share

  • The company has a price to earnings growth (PEG) ratio of 1.81 — a number near or below 1 signifying that Welltower is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 1.91 compared to its sector average of 2.24

  • Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure.

  • Based in Toledo, the company has 514 full time employees and a market cap of $41.37 Billion. Welltower currently returns an annual dividend yield of 3.1%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.